This appointment reinforces the commitment of Technoflex, European leader in the design and production of flexible bags, to pursue its ambitious internationally-oriented strategy.
In July, Olivier Chesnoy became the Technoflex Group’s CEO to develop its offering in the field of flexible packaging and medical devices for pharmaceutical use, particularly in high growth potential markets like the United States, India and Latin America.
“Our advanced technology and our in-house R&D capability now enable us to offer our customers innovative, reliable turnkey solutions which are easy to use in the hospital environment”, states Olivier Chesnoy.
The Technoflex Group – listed on the open market since 2003 – with a turnover of 38 million euros in 2010, already exports 65 % of its production to around fifteen countries.
Olivier Chesnoy, 52, medical doctor and graduate of the prestigious ESSEC Business School, has over 20 years’ experience in the health industries (pharmaceutical industry, biotechnologies, etc.). In particular he developed and created subsidiaries in Asia, including China, for the Fournier Group, and was also the head of its Spanish subsidiary. After managing a biotechnology company, he was until recently again based in Spain, where he turned around the Urgo Laboratories subsidiary.
“Olivier Chesnoy’s experience in the pharmaceutical world and internationally will be key advantages for implementing our development strategy”, says Philippe Destenbert, Technoflex Chairman.
